Pancreatic cancer is one of the deadliest forms of cancer. So any bit of progress on the pancreatic cancer front is a big deal. And researchers are happy to report they've found a chemotherapy drug that can help patients who have received surgery prevent a return of the disease for a longer period of time.In a German study, participants who received Gemzar, or gemcitabine, lived an average of 13.4 months without their cancers coming back. Participants who did not receive the drug lived without the disease for 6.9 months. While the findings of this study may seem modest, they really are quite encouraging because pancreatic cancer is such a rapid killer, and patients with this disease have the worst chances of recovery.
This study, published in Wednesday's Journal of the American Medical Association, brings hope for the mere 20 percent of pancreatic cancer patients who are candidates for surgery. While surgery is the best hope for a cure, the disease still returns in the majority of cases -- so Gemzar is surely worth a shot.
It should be noted that some study authors report financial ties to Gemzar drugmaker Eli Lilly and Co. Researchers, however, report the firm had no influence in design or data interpretation.


Most of us know her as Elyse Keaton on the long-time ago sitcom Family Ties. Many also know her from the variety of characters she has portrayed on television specials and movies. And Meredith Baxter is also known for her support of breast cancer research -- something not so apparent or obvious but just as significant in the scope of her life in the spotlight. Like many issues she speaks out on -- women's rights, gun control, state legislative matters -- breast cancer is an issue about which she is passionate. She has appeared at 







